These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14748200)

  • 81. Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis.
    Stege H; Hofmann B; Ruzicka T; Lehmann P
    Arch Dermatol; 1998 May; 134(5):640. PubMed ID: 9606345
    [No Abstract]   [Full Text] [Related]  

  • 82. Long-Term Multiple Center Experience in Treating Plaque Psoriasis With Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion.
    Abduelmula A; Gooderham MJ
    J Cutan Med Surg; 2023; 27(3):291-292. PubMed ID: 36942447
    [No Abstract]   [Full Text] [Related]  

  • 83. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study.
    Bianchi L; Soda R; Diluvio L; Chimenti S
    Br J Dermatol; 2003 Jul; 149(1):207-9. PubMed ID: 12890227
    [No Abstract]   [Full Text] [Related]  

  • 84. A novel halobetasol propionate 0.01%/tazarotene 0.045% fixed combination treatment for psoriasis.
    Radonjic A; Evans EL
    Dermatol Ther; 2019 Jul; 32(4):e12979. PubMed ID: 31155813
    [No Abstract]   [Full Text] [Related]  

  • 85. [Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
    Sander P; Happe M; Stücker M; Hermes N; Hoffmann K; Altmeyer P
    Hautarzt; 1999 Oct; 50(10):723-7. PubMed ID: 10550358
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Instrumental evaluation of retinoid-induced skin irritation.
    Stücker M; Hoffmann M; Altmeyer P
    Skin Res Technol; 2002 May; 8(2):133-40. PubMed ID: 12060479
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Follicular dyskeratosis: successful treatment with local retinoid].
    Oster-Schmidt C; Stücker M; Altmeyer P
    Hautarzt; 2000 Mar; 51(3):196-9. PubMed ID: 10789083
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Confluent and reticulated papillomatosis: response to tazarotene.
    Bowman PH; Davis LS
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S80-1. PubMed ID: 12734485
    [TBL] [Abstract][Full Text] [Related]  

  • 89. DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion for Topical Use: A Newly Approved Combination Corticosteroid and Retinoid Topical Treatment of Plaque Psoriasis in Adults.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(3):181-183. PubMed ID: 31496472
    [No Abstract]   [Full Text] [Related]  

  • 90. Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis.
    Sebök B; Bonnekoh B; Kerényi M; Gollnick H
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):285-91. PubMed ID: 10940819
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Excerpt of panel discussion from symposium.
    Cutis; 1998 Feb; 61(2 Suppl):30-5. PubMed ID: 9787990
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of occupational koilonychia with tazarotene gel.
    Hagman JH; Ginebri A; Mordenti C; De Simoni I; Chimenti S
    Acta Derm Venereol; 2003; 83(4):296-7. PubMed ID: 12926806
    [No Abstract]   [Full Text] [Related]  

  • 93. Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene.
    Orlandi A; Bianchi L; Costanzo A; Campione E; Giusto Spagnoli L; Chimenti S
    J Invest Dermatol; 2004 Apr; 122(4):1037-41. PubMed ID: 15102095
    [TBL] [Abstract][Full Text] [Related]  

  • 94. ARAZLO (Tazarotene 0.045%) Lotion for Topical Treatment of Acne Vulgaris.
    Gupta AK; Bruce A; Abramovits W
    Skinmed; 2020; 18(2):102-105. PubMed ID: 32501793
    [No Abstract]   [Full Text] [Related]  

  • 95. [From the Cochrane Library: Improvement of photodamaged skin with retinoid creams and not with other local treatments].
    Hamerlynck JV; Middeldorp S; Scholten RJ
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):140-2. PubMed ID: 16463616
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid.
    Behrens S; Grundmann-Kollmann M; Peter RU; Kerscher M
    Br J Dermatol; 1999 Jul; 141(1):177. PubMed ID: 10417841
    [No Abstract]   [Full Text] [Related]  

  • 97. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application.
    Duvic M; Ni X; Talpur R; Herne K; Schulz C; Sui D; Ward S; Joseph A; Hazarika P
    J Invest Dermatol; 2003 Oct; 121(4):902-9. PubMed ID: 14632211
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Optimizing therapy: tazarotene in combination with phototherapy.
    Lowe NJ
    Br J Dermatol; 1999 Apr; 140 Suppl 54():8-11. PubMed ID: 10731128
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tazarotene gel for Darier's disease.
    Burkhart CG; Burkhart CN
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):1001-2. PubMed ID: 9632016
    [No Abstract]   [Full Text] [Related]  

  • 100. Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma.
    Peris K; Ferrari A; Fargnoli MC; Piccolo D; Chimenti S
    Dermatol Surg; 2005 Feb; 31(2):217-20. PubMed ID: 15762218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.